Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02145156 · ClinicalTrials.gov registry record · NA
Educational Intervention to Minimize Disparities in Humanpapillomavirus Vaccination
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 1,294
- Enrollment target
NCT02145156: Completed NA study, sponsored by University of Colorado, Denver.
NCT02145156 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 1,294 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02145156, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,294 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate an innovative approach to improving HPV vaccination among the Hispanic population. The clinical objectives/aims of this HPV educational intervention project are to determine: 1. The number of young adults and adolescents in each arm who received any dose of the HPV vaccine during the study period, 2. The number of young adults and adolescents in each arm who initiated the HPV vaccine series during the study period, 3. The number of young adults and adolescents in each arm who initiated but did not complete the HPV vaccine series during the study period, 4. The number of young adults and adolescents in each arm, among all eligible, who completed the HPV vaccine series during the study period, 5. The number of young adults and adolescents in each arm who completed the HPV vaccine series during the study period, among those who initiated the series at study start, and 6. The number of young adults and adolescents in each arm who completed the HPV vaccine series among those who initiated the series during the study period. The implementation of this educational intervention in clinic waiting rooms is intended to assist primary care providers in communicating HPV vaccine awareness and education to parents and patients in a culturally tailored format.
Primary Outcome
This outcome describes the number of young adult participants between the ages of 18-26 who received any dose of the HPV vaccine during the study period.
Interventions
- BEHAVIORAL Tailored educational materials
- BEHAVIORAL Untailored educational materials
- BEHAVIORAL Survey-only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,294 participants |
| Start Date | 2014-06 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT02145156 record still lists
NCT02145156 is an interventional study that assigns participants to a tested intervention. Its 1,294 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Tailored educational materials is the first listed.
NCT02145156 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02145156 about?
NCT02145156 is a clinical study titled "Educational Intervention to Minimize Disparities in Humanpapillomavirus Vaccination". The purpose of this study is to evaluate an innovative approach to improving HPV vaccination among the Hispanic population. The clinical objectives/aims of this HPV educational intervention project are to determine: 1. The number of young adults and adolescents in each arm who received any dose of ...
What is the current status of trial NCT02145156?
This trial is currently completed. It is a NA study. The enrollment target is 1,294 participants. The study started on 2014-06. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02145156?
The interventions under investigation include: Tailored educational materials (BEHAVIORAL), Untailored educational materials (BEHAVIORAL), Survey-only (BEHAVIORAL).
Who is sponsoring clinical trial NCT02145156?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02145156's enrollment target sits among peer trials
1,294 78th of 2000 higher than 1,923 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05812807 · 1,295 participants · Phase 3
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
- NCT05595642 · 1,290 participants · Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia